Survival after surgical treatment for primary hyperparathyroidism. (Q50914762)

25 March 2018

title

Survival after surgical treatment for primary hyperparathyroidism. (English)

1 reference

25 March 2018

1 reference

Söreide JA

1

1 reference

25 March 2018

van Heerden JA

2

1 reference

25 March 2018

Grant CS

3

1 reference

25 March 2018

Yau Lo C

4

1 reference

25 March 2018

Schleck C

5

1 reference

25 March 2018

Ilstrup DM

6

1 reference

25 March 2018

language of work or name

1 reference

1 December 1997

1 reference

25 March 2018

published in

Surgery

1 reference

25 March 2018

volume

122

1 reference

25 March 2018

issue

6

1 reference

25 March 2018

page(s)

1117-1123

1 reference

25 March 2018

Surgical treatment of primary hyperparathyroidism: an institutional perspective.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2897%2990216-6

7 January 2021

Primary hyperparathyroidism. Low surgical morbidity supports liberal attitude to operation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2897%2990216-6

7 January 2021

Surgical therapy of patients with primary hyperparathyroidism: long-term benefits

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2897%2990216-6

7 January 2021

Cardiovascular risk factors in primary hyperparathyroidism: a 15-year follow-up of operated and unoperated cases

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2897%2990216-6

7 January 2021

Long-term effects of parathyroidectomy for primary hyperparathyroidism on arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2897%2990216-6

7 January 2021

The risk of hip fractures in patients with primary hyperparathyroidism: a population-based cohort study with a follow-up of 19 years

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2897%2990216-6

7 January 2021

Malignant neoplasms and parathyroid adenoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2897%2990216-6

7 January 2021

Increased risk of malignant diseases after surgery for primary hyperparathyroidism. A nationwide cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2897%2990216-6

7 January 2021

Premature death in patients operated on for primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2897%2990216-6

7 January 2021

The influence of surgery on the risk of death in patients with primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2897%2990216-6

7 January 2021

Characteristics of patients surgically treated for primary hyperparathyroidism with and without renal stones.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2897%2990216-6

7 January 2021

Asymptomatic primary hyperparathyroidism: the case for conservative management

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2897%2990216-6

7 January 2021

The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2897%2990216-6

7 January 2021

Psychologic symptoms before and after parathyroid surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2897%2990216-6

7 January 2021

Clinical evaluation of total serum calcium in primary hyperparathyroidism and the risk of death after surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2897%2990216-6

7 January 2021

Long-term health risk of primary hyperparathyroidism: the effect of surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2897%2990216-6

7 January 2021

10.1016/S0039-6060(97)90216-6

Identifiers

DOI

1 reference

25 March 2018

PubMed ID

9426427

1 reference

25 March 2018